Only 19.3 percent of patients referred from tertiary general hospitals were confirmed to have received follow-up care at ...

Vaxcellbio's experimental natural killer (NK) cell therapy, VCB-1102, combined with hepatic arterial infusion chemotherapy ...

SEERS has received ethics approval in Abu Dhabi to begin a pilot of its AI-based arrhythmia screening service, a final step ...

Nearly 30,000 people in Korea have type 1 diabetes, with adults accounting for more than 70 percent of newly diagnosed cases, ...

Mold-covered walls, cockroach-infested rooms and patients with limited mobility who cannot even contemplate visiting a ...

Sky Labs said Friday that more patients reached their target blood pressure (BP) when doctors adjusted medication using its ...

Urologists have called for measures to narrow regional disparities in prostate cancer diagnosis and improve reimbursement for ...

HLB said Thursday that it expects its cholangiocarcinoma (CCA) drug Lyrfigtu (lirafugratinib) to be priced 15 to 20 percent ...

LigaChem Biosciences has dosed the first patient in a global phase 1/2 trial of LCB02A, its experimental antibody-drug ...

The Ministry of Food and Drug Safety (MFDS) said Thursday it had approved Jascayd (nerandomilast), a treatment for idiopathic ...

The Korean Diabetes Association (KDA) said Thursday it is developing an AI chatbot with Korea’s internet portal giant Naver ...

Humedix is set to highlight the outstanding product quality of its flagship derma cosmetic brand, elravie.Humedix, an ...